Kathryn Weston
Rheumatology · Largo, FLNPI 1477131647
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.8% of the total across 206 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 23 manufacturers reported payments, led by Sanofi at 30.3% of the total. 2025 is the largest year on record at $5,508, more than ten times the $136 reported in 2022.
Across 206 payments — averaging $43.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$3K
- AbbVie$2K
- Amgen$1K
- Johnson & Johnson$862
- GSK$668
- UCB, Inc.$292
- plus $1K from 17 others
What the payments were for
- Food & beverage$8,78498%
- Education$1942%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 21 | $2,721 |
| AbbVie | 43 | $1,638 |
| Amgen(2 entities) | 37 | $1,330 |
| Johnson & Johnson | 17 | $862 |
| GSK | 20 | $668 |
| UCB, Inc. | 23 | $292 |
| Pfizer | 16 | $283 |
| Janssen Scientific Affairs, LLC | 2 | $242 |
| MML US, Inc. | 1 | $131 |
| Kiniksa Pharmaceuticals, Ltd. | 2 | $130 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $108 |
| Lilly USA, LLC | 3 | $106 |
| AstraZeneca | 2 | $99 |
| Fresenius Kabi USA, LLC | 4 | $76 |
| Novartis | 1 | $75 |
| Boehringer Ingelheim | 3 | $64 |
| Sobi, Inc | 2 | $34 |
| Novo Nordisk | 2 | $31 |
| Lucid Diagnostics Inc. | 1 | $19 |
| ANI Pharmaceuticals, Inc. | 1 | $18 |
| Radius Health, Inc. | 1 | $18 |
| LEO Pharma Inc. | 1 | $18 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,978 in reported general payments places this provider in the 55th percentile of 453 rheumatology providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MethotrexateMethotrexate Sodium | 13 | $163 |
Paid to pharmacies, not to this prescriber.
Other rheumatology in Largo
- Rubaiya MallayLargo$292K
- Alvin WellsDestin$2.4M
- Guillermo ValenzuelaPlantation$1.5M
- Julio Gonzalez-PaoliTampa$1.4M
- Ernesto RodriguezZephyrhills$958K
- Vinicius Costa Diniz DominguesDaytona Beach$921K
- Jonathan GreerBoynton Beach$757K
- Jigar ShahMargate$750K
- Rachel TateHollywood$729K
- Howard BuschLoxahatchee$717K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.